Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

TM6SF2/PNPLA3/MBOAT7 Loss-of-Function Genetic Variants Impact on NAFLD Development and Progression Both in Patients and in In Vitro Models
Miriam Longo, Marica Meroni, Erika Paolini, et al.
Cellular and Molecular Gastroenterology and Hepatology (2021) Vol. 13, Iss. 3, pp. 759-788
Open Access | Times Cited: 76

Showing 26-50 of 76 citing articles:

Genetic Predictors of Comorbid Course of COVID-19 and MAFLD: A Comprehensive Analysis
Mykhailo Buchynskyi, Valentyn Oksenych, Iryna Kamyshna, et al.
Viruses (2023) Vol. 15, Iss. 8, pp. 1724-1724
Open Access | Times Cited: 11
Advances in genetic variation in metabolism-related fatty liver disease
Fan Shi, Mei Zhao, Shudan Zheng, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 11
Nonalcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma: The Next Threat after Viral Hepatitis
Mohamed Salaheldin, Heba Aly, Louis Ho Shing Lau, et al.
Diagnostics (2023) Vol. 13, Iss. 16, pp. 2631-2631
Open Access | Times Cited: 10
Unraveling the pathogenesis of non‐alcoholic fatty liver diseases through genome‐wide association studies
Ye Tian, Bo Wang
Journal of Gastroenterology and Hepatology (2023) Vol. 38, Iss. 11, pp. 1877-1885
Open Access | Times Cited: 10
Metabolic dysfunction−associated liver disease and diabetes: Matrix remodeling, fibrosis, and therapeutic implications
Weiguo Fan, Toby M. Bradford, Natalie J. Török
Annals of the New York Academy of Sciences (2024) Vol. 1538, Iss. 1, pp. 21-33
Closed Access | Times Cited: 3
Deep metabolic phenotyping of humans with protein-altering variants in TM6SF2 using a genome-first approach
Helen Huang, Cecilia Vitali, David Zhang, et al.
JHEP Reports (2024) Vol. 7, Iss. 1, pp. 101243-101243
Open Access | Times Cited: 3
Microbiota–Liver Diseases Interactions
Rosanna Capparelli, Paola Cuomo, Antonio Gentile, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3883-3883
Open Access | Times Cited: 9
High-density lipoproteins and non-alcoholic fatty liver disease
Menno Hoekstra, Miranda Van Eck
Atherosclerosis Plus (2023) Vol. 53, pp. 33-41
Open Access | Times Cited: 9
MBOAT7 in liver and extrahepatic diseases
Andrea Caddeo, Rocco Spagnuolo, Samantha Maurotti
Liver International (2023) Vol. 43, Iss. 11, pp. 2351-2364
Open Access | Times Cited: 9
Meeting at the Crossroad between Obesity and Hepatic Carcinogenesis: Unique Pathophysiological Pathways Raise Expectations for Innovative Therapeutic Approaches
Konstantinos Arvanitakis, Stavros P. Papadakos, Vasileios Lekakis, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14704-14704
Open Access | Times Cited: 9
The Non-Invasive Assessment of Circulating D-Loop and mt-ccf Levels Opens an Intriguing Spyhole into Novel Approaches for the Tricky Diagnosis of NASH
Erika Paolini, Miriam Longo, Alberto Corsini, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2331-2331
Open Access | Times Cited: 8
Coagulation Dysfunctions in Non-Alcoholic Fatty Liver Disease—Oxidative Stress and Inflammation Relevance
Madalina Andreea Robea, Ioana-Miruna Balmuș, Irina Gîrleanu, et al.
Medicina (2023) Vol. 59, Iss. 9, pp. 1614-1614
Open Access | Times Cited: 8
Are we ready for genetic testing in metabolic dysfunction‐associated steatotic liver disease?
Adele Tulone, Grazia Pennisi, Carlo Ciccioli, et al.
United European Gastroenterology Journal (2024) Vol. 12, Iss. 5, pp. 638-648
Open Access | Times Cited: 2
Racial and ethnic disparities in metabolic dysfunction-associated steatotic liver disease outcomes: A call for culturally sensitive interventions: Editorial on “Differences in liver and mortality outcomes of non-alcoholic fatty liver disease by race and ethnicity: A longitudinal real-world study”
Jae Hyun Bae
Clinical and Molecular Hepatology (2024) Vol. 30, Iss. 4, pp. 665-668
Open Access | Times Cited: 2
Genetics, Immunity and Nutrition Boost the Switching from NASH to HCC
Paola Dongiovanni, Marica Meroni, Miriam Longo, et al.
Biomedicines (2021) Vol. 9, Iss. 11, pp. 1524-1524
Open Access | Times Cited: 19
Metabolic Risks Are Increasing in Non-B Non-C Early-Stage Hepatocellular Carcinoma: A 10-Year Follow-Up Study
Yen‐Po Lin, Peiming Wang, Ching‐Hui Chuang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 13
Cutting-Edge Therapies and Novel Strategies for Acute Intermittent Porphyria: Step-by-Step towards the Solution
Miriam Longo, Erika Paolini, Marica Meroni, et al.
Biomedicines (2022) Vol. 10, Iss. 3, pp. 648-648
Open Access | Times Cited: 12
Cardiometabolic risk factors in MASLD patients with HCC: the other side of the coin
Marica Meroni, Miriam Longo, Paola Dongiovanni
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 2
Human-induced pluripotent stem cell–based hepatic modeling of lipid metabolism–associated TM6SF2-E167K variant
Lanuza A. P. Faccioli, Yiyue Sun, Olamide Animasahun, et al.
Hepatology (2024)
Open Access | Times Cited: 2
From adiposity to steatosis: metabolic dysfunction-associated steatotic liver disease, a hepatic expression of metabolic syndrome – current insights and future directions
Bruno Basil, B. Myke-Mbata, Onyinye Ezinne Eze, et al.
Clinical Diabetes and Endocrinology (2024) Vol. 10, Iss. 1
Closed Access | Times Cited: 2
Non-Alcoholic Fatty Liver Disease and Extrahepatic Cancers: A Wolf in Sheep’s Clothing?
Athanasia Mitsala, Christos Tsalikidis, Κonstantinos Romanidis, et al.
Current Oncology (2022) Vol. 29, Iss. 7, pp. 4478-4510
Open Access | Times Cited: 11
Utility of Human Relevant Preclinical Animal Models in Navigating NAFLD to MAFLD Paradigm
Damien Chua, Zun Siong Low, Guo Xiang Cheam, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14762-14762
Open Access | Times Cited: 11
High producer variant of lipoprotein lipase may protect from hepatocellular carcinoma in alcohol-associated cirrhosis
Franziska Schmalz, Janett Fischer, Hamish Innes, et al.
JHEP Reports (2023) Vol. 5, Iss. 4, pp. 100684-100684
Open Access | Times Cited: 5
An Overview of Hepatocellular Carcinoma Surveillance Focusing on Non-Cirrhotic NAFLD Patients: A Challenge for Physicians
Annalisa Cespiati, Felice Cinque, Marica Meroni, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 586-586
Open Access | Times Cited: 5
The I148M PNPLA3 variant mitigates niacin beneficial effects: How the genetic screening in non-alcoholic fatty liver disease patients gains value
Erika Paolini, Miriam Longo, Marica Meroni, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 5

Scroll to top